# Nelarabine

NDC: 70771-1685
Generic name: Nelarabine
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20211117

FDA application: ANDA215037

## Active ingredients

- NELARABINE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1685"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1685
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=877b69a0-0899-455d-926e-f5a7478c31f8